OKT3 VS FK-506 RESCUE MANAGEMENT OF ACUTE STEROID-RESISTANT AND CHRONIC REJECTION

被引：0
|
作者：
PLATZ, KP
MUELLER, AR
ZYTOWSKI, M
BECHSTEIN, WO
BLUMHARDT, G
LOBECK, H
NEUHAUS, P
机构：
[1] FREE UNIV BERLIN,DEPT SURG,W-1000 BERLIN,GERMANY
[2] FREE UNIV BERLIN,DEPT PATHOL,W-1000 BERLIN,GERMANY
来源：
TRANSPLANTATION PROCEEDINGS | 1995年 / 27卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：1111 / 1113
页数：3
相关论文
共 50 条
  • [31] Half dose of OKT3 is efficient in treatment of steroid-resistant renal allograft rejection
    Midtvedt, K
    Tafjord, AB
    Hartmann, A
    Eide, TC
    Holdaas, H
    Nordal, KP
    Draganov, B
    Sodal, G
    Leivestad, T
    Fauchald, P
    TRANSPLANTATION, 1996, 62 (01) : 38 - 42
  • [32] INCIDENCE AND OUTCOME OF OKT3 THERAPY FOR STEROID-RESISTANT HEPATIC ALLOGRAFT-REJECTION
    ROBERTS, S
    BRADLEY, A
    STEERS, JL
    PAYA, C
    KROM, RAF
    WIESNER, RH
    HEPATOLOGY, 1995, 22 (04) : 1496 - 1496
  • [33] FK-506 IN THE MANAGEMENT OF TRANSPLANT-RELATED NEPHROTIC SYNDROME AND STEROID-RESISTANT NEPHROTIC SYNDROME
    MCCAULEY, J
    SHAPIRO, R
    SCANTLEBURY, V
    GILBOA, N
    JORDAN, M
    JENSEN, C
    NAIK, A
    TZAKIS, A
    ELLIS, D
    STARZL, TE
    TRANSPLANTATION PROCEEDINGS, 1991, 23 (06) : 3354 - 3356
  • [34] CYCLOSPORINE AND OKT3 SALVAGE FOR STEROID-RESISTANT AND ATG-RESISTANT RENAL-TRANSPLANT REJECTION
    FLYE, W
    KASHGARIAN, M
    GAUDIO, K
    SIEGEL, N
    SMITH, D
    KLIGER, A
    SCHIFF, M
    BIA, MJ
    TRANSPLANTATION PROCEEDINGS, 1985, 17 (06) : 2748 - 2750
  • [35] Tacrolimus treatment of steroid-resistant rejection provides economic advantages compared with OKT3 therapy
    Millis, JM
    Cronin, DC
    Newell, KA
    Piper, JB
    Woodle, ES
    Bruce, DS
    Conjeevaram, H
    Baker, AL
    Thistlethwaite, JR
    TRANSPLANTATION PROCEEDINGS, 1997, 29 (1-2) : 1549 - 1549
  • [36] OUTCOME ANALYSIS OF FK-506 THERAPY FOR ACUTE AND CHRONIC REJECTION
    GIBBS, JF
    HUSBERG, BS
    KLINTMALM, GB
    BACKMAN, L
    LEVY, M
    MCMILLAN, R
    GOLDSTEIN, RM
    HOLMAN, MJ
    GONWA, TA
    MORRIS, C
    TRANSPLANTATION PROCEEDINGS, 1993, 25 (01) : 622 - 623
  • [37] OKT3 FOR STEROID-RESISTANT RENAL-ALLOGRAFT REJECTION - DIFFERENTIAL RESPONSE IN ADULTS AND CHILDREN
    SHMUELI, D
    NAKACHE, R
    LUSTIG, S
    BARNATHAN, N
    YUSSIM, A
    SHAHARABANI, E
    GEIER, A
    SHAPIRA, Z
    TRANSPLANTATION PROCEEDINGS, 1994, 26 (04) : 1948 - 1949
  • [38] OKT3 MONOCLONAL-ANTIBODY TREATMENT OF STEROID-RESISTANT LIVER-TRANSPLANT REJECTION
    HAVERTY, TP
    SANDERS, MK
    SHEAHAN, MM
    DANIEL, DA
    SPENCE, SC
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1994, 55 (04): : 382 - 395
  • [39] INCIDENCE AND OUTCOME OF OKT3 TREATMENT FOR EARLY STEROID-RESISTANT REJECTION FOLLOWING HEPATIC TRANSPLANTATION
    LANGE, D
    BECHSTEIN, WO
    BLUMHARDT, G
    LEMMENS, P
    SCHATTENFROH, N
    NEUHAUS, P
    TRANSPLANTATION PROCEEDINGS, 1993, 25 (02) : 1870 - 1871
  • [40] Severe thrombocytopenia with OKT3 use for steroid-resistant rejection in a cadaveric renal transplant recipient
    Mackie, F
    Verran, D
    Horvath, J
    Tiller, D
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1996, 11 (11) : 2378 - 2378
12345